IMGO NASDAQ
Imago BioSciences, Inc.
1W: +0.1%
1M: +0.4%
3M: +131.3%
1Y: +81.7%
$36.01
Last traded 2023-01-10 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$42M
-132.4% ▼
Net Income
-$42M
-137.3% ▼
EPS (Diluted)
$-1.26
-59.5% ▼
EBITDA
-$43M
-139.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Gross Margin | — | — | — |
| R&D Expenses | $8M | $15M | $32M |
| SG&A Expenses | $2M | $3M | $10M |
| Operating Expenses | $11M | $18M | $43M |
| Operating Income | -$11M | -$18M | -$42M |
| Operating Margin | — | — | — |
| Interest Expense | $38K | $48K | $314K |
| Income Before Tax | -$11M | -$18M | -$42M |
| Tax Expense | $0 | $3K | $2K |
| Net Income | -$11M | -$18M | -$42M |
| Net Margin | — | — | — |
| EPS (Diluted) | $-0.49 | $-0.79 | $-1.26 |
| EBITDA | -$11M | -$18M | -$43M |
| Shares Outstanding | 22M | 22M | 34M |